INSM Q1 2022 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$53M+32.1% YoY

Gross Profit

$41M77.0% margin

Operating Income

-$90M-169.2% margin

Net Income

-$95M-178.2% margin

EPS (Diluted)

$-0.80

QoQ Revenue Growth

-5.4%

Cash Flow

Operating Cash Flow

-$105M

Free Cash Flow

-$107M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$1.0B

Stockholders' Equity

$120M

Cash & Equivalents

$516M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$40M	+32.1%
Gross Profit	$41M	$30M	+34.7%
Operating Income	-$90M	-$84M	-7.2%
Net Income	-$95M	-$92M	-3.3%

Geographic Segments

JAPAN

$11M75%

UNITED STATES

$4M25%